FibroBiologics, Inc. Shares Outstanding (Cover Page)
FibroBiologics, Inc. (FBLG) had Shares Outstanding (Cover Page) of 6.66 million shares as of 2026-07-31, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-31
- 2026-07-31: Entity Common Stock, Shares Outstanding 6.66M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 5.21M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 67.59M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 51.46M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 6.66M shares 10-Q · filed 2026-07-31 |
| 2026-05-01 | 5.21M shares 10-Q · filed 2026-04-30 |
| 2026-02-24 | 67.59M shares 10-K/A · filed 2026-03-13 |
| 2025-10-31 | 51.46M shares 10-Q · filed 2025-10-31 |
| 2025-07-30 | 41.89M shares 10-Q · filed 2025-07-31 |
| 2025-05-13 | 38.26M shares 10-Q · filed 2025-05-14 |
| 2025-03-28 | 37.74M shares 10-K · filed 2025-03-31 |
| 2024-11-11 | 34.66M shares 10-Q · filed 2024-11-12 |
| 2024-08-06 | 35.16M shares 10-Q · filed 2024-08-07 |
| 2024-05-14 | 32.72M shares 10-Q · filed 2024-05-14 |
| 2024-02-20 | 32.63M shares 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |